Search research articles
Contact Us
Filters
Showing results (501-510 of 531) with videos related to
Page
of 54
Sort By:
Arthritis Care & Research
|
November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus
Emily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Physical Activity & Health
|
June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination
Fabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study
Leonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases
|
February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Rheumatology (Oxford, England)
|
October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Plos One
|
November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients
João L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
Stephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Annals of Neurology
|
June 20, 2025
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 531) with videos related to
Sort By:
Page
of 54
Arthritis Care & Research
|
November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus
Emily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Physical Activity & Health
|
June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination
Fabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study
Leonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases
|
February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Rheumatology (Oxford, England)
|
October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Plos One
|
November 17, 2011
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients
João L Miraglia, Edson Abdala, Paulo M Hoff, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 10, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla G S Saad, Sofia M Sieczkowska, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
Stephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Annals of Neurology
|
June 20, 2025
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Page
of 54